Climb Bio Cash Flow Statement (2020-2026) | CLYM

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-8.71M-9.38M-10.70M-13.13M-13.55M-8.37M-8.79M-22.54M-5.60M-3.74M-3.77M-1.66M-54.89M-8.95M-8.39M-20.73M-8.50M-12.86M-17.47M-13.70M
Share-based Compensation (Quarter)
1.05M1.24M1.15M1.54M1.77M1.78M1.90M10.17M0.78M0.66M1.20M0.47M0.51M2.92M1.66M2.02M1.01M3.98M1.04M1.60M
Gains from Sales and Divestitures (Quarter)
0.01M0.02M0.03M0.01M0.09M0.11M0.15M0.02M0.06M0.09M0.12M0.02M0.40M0.40M0.40M0.40M0.51M0.93M0.93M563.00
Gains from Investment Securities (Quarter)
2.64M2.39M4.28M4.57M4.53M0.25M0.05M0.94M1.81M6.42M0.01M1.41M1.30M0.15M
Cash from Restructuring (Quarter)
0.20M
Non-cash Items (Quarter)
9.20M41.73M21.14M15.97M1.23M1.50M5.70M4.05M4.37M1.32M1.06M3.79M2.79M0.94M0.02M0.80M1.04M1.61M11.73M1.33M
Cash from Operations (Quarter)
-8.48M-12.97M-7.88M-10.78M-13.97M-4.17M-8.45M-15.18M-7.96M3.49M-0.95M-1.82M-0.67M-7.55M-5.52M-15.43M-11.15M-12.14M-15.63M-14.38M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.08M-0.29M-0.19M-0.10M0.07M0.40M0.49M0.74M0.75M0.35M0.06M0.17M0.53M0.67M0.57M0.52M0.51M0.30M
Depreciation & Amortization (CF) (Quarter)
0.04M0.03M0.03M0.04M
Change in Working Capital
Change in Account Payables (Quarter)
-0.05M0.42M-0.97M-0.56M0.23M0.41M-0.74M0.11M0.01M-0.14M-0.67M0.02M-1.18M-0.22M0.41M0.07M0.09M-0.39M1.79M-1.41M
Change in Accured Expenses (Quarter)
1.77M-0.62M1.41M0.97M0.50M-1.66M0.61M-1.46M-1.33M2.79M-0.74M1.07M0.10M1.02M2.04M-1.09M-0.79M-0.15M-1.53M
Investing Activities
Capital Expenditures (Quarter)
0.11M
Change in Acquisitions & Divestments (Quarter)
21.55M24.61M55.25M20.99M23.25M36.93M30.50M36.75M13.75M7.00M16.00M25.48M39.08M30.53M31.90M
Cash from Investing Activities (Quarter)
-106.92M-8.05M-4.04M15.69M8.51M14.28M5.80M-1.60M28.04M36.75M13.75M-9.64M-71.79M-53.41M-42.75M4.79M15.26M25.54M-12.96M
Financing Activities
Change in Capital Stock
Shares Issued (Quarter)
0.01M83.03M-83.00M0.00M0.02M0.53M0.29M0.01M119.75M2.27M0.04M0.01M
Preferred Shares Issued (Quarter)
93.91M
Misc.
Cash from Financing Activities (Quarter)
59.97M83.14M0.04M0.00M0.02M0.53M0.29M0.01M128.40M2.27M0.04M-0.02M0.01M
Exchange Rate Effect (Quarter)
0.09M0.08M-0.18M-1.05M-0.99M1.81M0.23M0.40M0.00M-0.33M-0.03M0.02M0.11M-0.06M-0.02M0.02M
Change in Cash (Quarter)
51.57M-36.66M-15.90M-14.99M0.67M3.34M7.64M-9.15M-9.14M32.06M35.76M11.92M118.11M-76.97M-58.95M-58.21M-6.34M3.12M9.88M-27.33M
Free Cash Flow (Quarter)
-8.48M-12.97M-7.88M-10.78M-13.97M-4.17M-8.45M-15.18M-7.96M3.49M-0.95M-1.82M-0.67M-7.55M-5.52M-15.43M-11.15M-12.25M-15.63M-14.38M
Net Cash Flow (Quarter)
51.49M-36.74M-15.90M-14.81M1.72M4.33M5.83M-9.38M-9.54M32.05M36.09M11.95M118.09M-77.07M-58.89M-58.19M-6.36M3.12M9.88M-27.33M